Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Neoplasms and DMD[original query] |
---|
Genomewide association analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia (MGS2) control sample.
Alcoholism, clinical and experimental research 2011 May 35 (5): 963-75. Kendler Kenneth S, Kalsi Gursharan, Holmans Peter A, Sanders Alan R, Aggen Steven H, Dick Danielle M, Aliev Fazil, Shi Jianxin, Levinson Douglas F, Gejman Pablo |
Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations. Oncotarget 2017 Jan 8 (1): 145-155. Luce Leonela N, Abbate Mercedes, Cotignola Javier, Giliberto Florenc |
Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. The Journal of clinical endocrinology and metabolism 2017 05 . Voss Rachel K, Feng Lei, Lee Jeffrey E, Perrier Nancy D, Graham Paul H, Hyde Samual M, Nieves-Munoz Frances, Cabanillas Maria E, Waguespack Steven G, Cote Gilbert J., Gagel Robert F, Grubbs Elizabeth |
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome. Acta neuropathologica 2018 8 136 (5): 779-792. Juratli Tareq A, McCabe Devin, Nayyar Naema, Williams Erik A, Silverman Ian M, Tummala Shilpa S, Fink Alexandria L, Baig Aymen, Martinez-Lage Maria, Selig Martin K, Bihun Ivanna V, Shankar Ganesh M, Penson Tristan, Lastrapes Matthew, Daubner Dirk, Meinhardt Matthias, Hennig Silke, Kaplan Alexander B, Fujio Shingo, Kuter Benjamin M, Bertalan Mia S, Miller Julie J, Batten Julie M, Ely Heather A, Christiansen Jason, Baretton Gustavo B, Stemmer-Rachamimov Anat O, Santagata Sandro, Rivera Miguel N, Barker Fred G, Schackert Gabriele, Wakimoto Hiroaki, Iafrate A John, Carter Scott L, Cahill Daniel P, Brastianos Priscilla |
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma. Cancer research 2018 Nov 78 (21): 6297-6307. Eleveld Thomas F, Schild Linda, Koster Jan, Zwijnenburg Danny A, Alles Lindy K, Ebus Marli E, Volckmann Richard, Tijtgat Godelieve A, van Sluis Peter, Versteeg Rogier, Molenaar Jan |
Genetic alterations and PIK3CA gene mutations and amplifications analysis in cervical cancer by racial groups in the United States. International journal of health sciences 0 12 (1): 28-32. Femi Odekunle Floren |
Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy. Journal of cardiovascular development and disease 2018 1 4 (2): . Serie Daniel J, Crook Julia E, Necela Brian M, Axenfeld Bianca C, Dockter Travis J, Colon-Otero Gerardo, Perez Edith A, Thompson E Aubrey, Norton Nadi |
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer. Clinical Medicine Insights. Oncology 2019 13 1179554919868482. Saravia César H, Flores Claudio, Schwarz Luis J, Bravo Leny, Zavaleta Jenny, Araujo Jhajaira, Neciosup Silvia, Pinto Joseph |
Identification of Genetic Variants Associated with Sex-Specific Lung-Cancer Risk. Cancers 2021 12 13 (24): . Shi Xiaoshun, Young Sylvia, Morahan Gra |
ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing. Frontiers in oncology 2022 4 12 769709. Wang Qi-Wen, Wang Xin-Yuan, Zhang Qing-Wei, Chen Jin-Nan, Zhou Yu-Jie, Tang Zhao-Rong, Wang Rui-Lan, Chen Haoyan, Chen Huimin, Li Xiao- |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: